Wound Closure Market Size, Share & Industry Analysis, By Product Type (Sutures [Absorbable and Non-absorbable], Hemostatic Agents [Active Hemostats, Passive Hemostats, Combination Hemostats, and Others], Staplers [Powered and Manual], and Others), By Application (Orthopedics, Gynecology and Obstetrics, General Surgery, Ophthalmology, Cardiology, and Others), By End-User (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2024-2032

The global wound closure market size was valued at USD 13.80 billion in 2023. The market is projected to grow from USD 14.59 billion in 2024 to USD 23.51 billion by 2032, exhibiting a CAGR of 6.1% during the forecast period. North America dominated the wound closure market with a market share of 37.68% in 2023.

Wound closure is one of the essential parts of emergency medicine, which refers to the techniques used to close a wound, including sutures, staplers, hemostats, and others. It is the final step of surgical intervention among patients. The growing prevalence of various chronic conditions, including cardiovascular, orthopedic conditions, among others, is further resulting in the growing demand for these products in the market.

• For instance, according to the 2022 article published by Frontiers Media S.A., it was reported that more than one out of three adults in the European Union (EU) have a long-standing or chronic health problem, and an increasing proportion of the chronically ill people suffer from multi-morbidity, having two or more conditions.

In addition, the increasing number of key players focusing on research and development activities to develop and introduce innovative products is another contributing factor to the global market size.

The COVID-19 pandemic impact on the global market was negative due to reduced demand for products owing to limited patient visits to hospitals and clinics for surgical procedures. Prominent players also witnessed a decline in revenues owing to reduced sales of the products globally.

Wound Closure Market Trends

Preferential Shift from Traditional to Modern Products for Wound Closure

There is an increasing preferential shift toward modern techniques owing to several drawbacks associated with traditional techniques, including inefficient wound closure and increased risk of infections, among others. The complications associated with these products are further resulting in the adoption of modern techniques among surgeons. Modern techniques offer increased efficacy and accuracy among the patient population.

The prominent players operating in the wound closure market are also focusing on research and development activities to develop and introduce novel staplers, hemostats, and other products.

• In May 2024, Johnson & Johnson Services, Inc. launched the ECHELON LINEAR Cutter in the U.S. It comprises 3D-Stapling Technology and Gripping Surface Technology (GST) to enable greater staple line security, reducing risks and supporting patient outcomes. The adoption of advanced products helps in the strong closure of the wound among patients.

Furthermore, the penetration rate for modern sutures, hemostats, staplers, and others is higher among patients in developed countries such as the U.S., the U.K., Germany, Japan, and others. The ongoing clinical trials for modern staplers, hemostats, sutures, and other products among the major players are further promoting the adoption of these products in the market.

The benefits mentioned above associated with advanced products have caused the shift from traditional techniques to modern techniques.

Wound Closure Market Growth Factors

Increasing Prevalence of Chronic Conditions and Diagnosis Among Patients to Boost Market Growth

The increasing prevalence of chronic conditions, including cardiovascular disorders, orthopedic disorders, among others, is resulting in a rising number of patient admissions in healthcare settings. The increasing number of patients is further supporting the rising number of surgical procedures, resulting in the emergence of various strategies and approaches to improve care for chronic conditions among patients.

• For instance, according to the 2022 data published by the National Health Survey conducted by the Australia Bureau of Statistics (ABS), around 7.3 million people are estimated to be living with chronic musculoskeletal conditions in Australia. Among these people, about 3.7 million people were estimated to be living with arthritis.

Similarly, the growing geriatric population is posing a major concern as they are highly prone to these conditions. The aging population is associated with the rising prevalence of these chronic conditions, further augmenting the number of surgical procedures among these patients globally.

• According to 2022 data published by the Australian Institute of Health and Welfare, it was reported that there are about 4.4 million of the population aged 65 and over in Australia.

In addition, there is a rising number of accidents and trauma cases, resulting in severe and chronic wounds, which may require immediate medical intervention among these patients. The growing rate of traumatic injuries is also likely to aid in the rising number of surgical procedures among these patients, further likely to boost the global wound closure market growth during the forecast period.

RESTRAINING FACTORS

High Costs Associated with Advanced Products May Limit Adoption

The continuous advancements in these products and their development costs are resulting in rising costs, further limiting the adoption rate, especially in emerging countries such as China, Poland, Brazil, among others. The high cost of these products is leading to their inaccessibility among the patient population.

• For instance, in December 2023, according to a study published by Springer Nature, it was reported that the average cost per patient in the powered stapler group was between USD 6,720 - 6,760 in the study in Spain.

Furthermore, the advancements such as the integration of nanotechnology, artificial intelligence, among others, are growing among market players for manufacturing these products owing to the growing demand. Thus, the cost associated with these materials is higher than that of traditional materials, resulting in the increasing cost and further increasing the price of surgical procedures among patients.

In addition, the lack of proper, adequate reimbursement policies for surgical procedures for chronic conditions such as cardiovascular disorders, gynecological disorders, and others among the majority of the emerging countries makes it difficult for the population to undergo treatment due to financial burden. Patients in low and middle-income countries (LMICs), including Southeast Asian countries and African countries, among others, find it challenging to afford these surgical procedures.

Thus, the limited number of surgical procedures, along with increasing costs, is hampering the adoption rate of these products in the market and is likely to limit the growth of the market.

Wound Closure Market Segmentation Analysis

By Product Type Analysis

Several Benefits Led to the Dominance of the Sutures Segment

Based on product type, the market is segmented into sutures, hemostatic agents, staplers, and others.

Furthermore, the sutures segment is bifurcated into absorbable and non-absorbable. The hemostatic agents segment is further segmented into active hemostats, passive hemostats, combination hemostats, and others. In addition, the staplers segment is divided into powered and manual.

The dominance of the sutures segment is due to several benefits of sutures, such as facilitation of proper skin healing, reduced bleeding, among others, resulting in the growing demand for sutures among the surgeons in the market. This, along with a rising number of technological advancements in surgical sutures, is likely to contribute to the growing adoption of these products in the market.

• For instance, in June 2023, researchers from the Sivas Cumhuriyet University in Turkey discovered that these coated suture surfaces significantly improved fibroblast attachment, migration, and proliferation while also stimulating the release of angiogenic growth factors to accelerate the wound healing process.

The hemostatic agents segment is expected to expand at a substantial growth rate during the forecast period. The growth is due to the rising focus of prominent players on research and development activities to launch novel hemostats, resulting in the growing adoption rate for these products in the market.

On the other hand, the staplers segment is also expected to grow with a considerable growth rate during the forecast period. The growth is due to the increasing demand for staplers among healthcare professionals. This, along with rising technological advancements among the key players, further resulting in the growing number of product launches for staplers is likely to support the segmental growth during the forecast period.

By Application Analysis

Growing Number of General Surgical Procedures Among the Population Led to the Dominance of General Surgery Segment

Based on application, the market is segmented into orthopedics, gynecology and obstetrics, general surgery, ophthalmology, cardiology, and others.

The general surgery segment dominated the market in 2023. The segmental growth is attributable to the rising number of general surgical procedures such as plastic surgery, breast surgery, oncology surgery, and others that are leading toward the adoption of these products for achieving hemostasis and wound healing.

• According to the data published by Eurostat surgical operations and procedure statistics in 2023, approximately 229 cholecystectomy and 191 laparoscopic cholecystectomy surgeries per 100,000 inhabitants were performed in Germany in 2021.

The cardiology segment is expected to grow with the highest CAGR during the forecast period. The increasing prevalence of cardiovascular diseases among patients is further resulting in the rising demand for these products in the market. This, along with the growing number of product launches among the key players, is likely to boost the adoption rate for these products in the market.

• According to the data published by Mass General Brigham in 2023, more than 900,000 cardiac surgeries are performed in the U.S., including coronary bypass surgeries. Such factors are expected to drive the segment’s growth.

On the other hand, the orthopedics segment is also expected to grow during the forecast period. The growth is due to the rising number of trauma cases and bone replacement surgeries leading toward the increased adoption of these products among the patient population.

Moreover, the gynecology and obstetrics segment held a notable share in 2023 owing to the increase in the number of cesarean sections and bariatric surgeries. In addition, increasing strategic activities by key companies for launching devices for bariatric surgeries is further propelling the growth of the segment.

Similarly, the ophthalmology and others segments are also expected to grow at a considerable growth rate during the forecast period. The increasing number of ophthalmological procedures among patients is further boosting the demand for these products in the market. This, along with a growing focus on research and development activities to launch innovative products, is likely to drive the growing adoption rate for these products in the market.

By End-User Analysis

Growing Number of Surgical Procedures in Hospitals & ASCs Globally Led to the Dominance of the Segment

The market is segmented into hospitals & ASCs, specialty clinics, and others, based on end-user.

The hospitals & ASCs segment dominated the market in 2023. The dominance of the segment is due to the increasing number of hospitals & ASCs in developed and emerging countries, resulting in the rising number of surgical procedures among the patient population in these settings. In addition, the presence of a large number of hospitals with advanced healthcare facilities and strong reimbursement policies augment the segment’s growth.

• For instance, according to the 2022 survey conducted by the American Hospital Association, there are about 6,120 hospitals in the U.S.

On the other hand, the specialty clinics segment is anticipated to grow at a considerable growth rate during the forecast period. The growth of the segment is due to certain benefits such as ease of accessibility, specialized care, and advanced facilities, among others. This, along with the growing number of specialty clinics, especially in developed countries, is further likely to boost the demand for advanced products in the market.

REGIONAL INSIGHTS

By geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America was valued at USD 5.20 billion in 2023 and dominated the market. The increasing number of surgical procedures, substantial healthcare expenditure & infrastructure, growing adoption rate, among others, are some of the factors contributing to the growth of the market in the region. This, along with the growing focus of key players on launching advanced products, is likely to support the growth of the region in the market.

• According to the 2022 data published by the American Society for Metabolic and Bariatric Surgery, 279,967 bariatric surgeries were performed among the patient population.

Europe is projected to witness substantial growth in the market during the study period. The segmental growth is due to the increasing prevalence of chronic diseases resulting in the growing number of surgical procedures in Europe. This, along with, increasing awareness initiatives by the government bodies for the use of antibiotic-induced sutures to reduce surgical site infections (SSIs) is likely to contribute to the growth of the market.

• In June 2021, the National Institute for Health and Care Excellence (NICE) issued new medical technologies guidance (MTG59) recommending the use of Plus Sutures in surgeries within the National Health Services to reduce the risk of SSIs.

On the other hand, Asia Pacific is also expected to grow during the forecast period. The growth is due to the growing geriatric population coupled with the growing incidence of diabetic foot ulcers, among others, resulting in a surge in the number of surgical procedures in the market. This, along with the growing focus of key players on research and development activities for launching and introducing innovative products, is further likely to support the growth of the region in the market.

• According to the 2022 statistics published by the Government of China, approximately 280.1 million people aged 60 years and above are in China.

Latin America and the Middle East & Africa are also expected to grow during the forecast period. The growth is due to increasing awareness about the benefits of advanced products such as sutures, staplers, hemostats, among others, resulting in the rising focus on acquisitions and mergers among the key players to strengthen their presence in the market. Thus, all the factors above are likely to support the growth of the market in these regions.

KEY INDUSTRY PLAYERS

Increasing Number of Product Approvals among the Key Players to Favor the Market Growth

The global market is semi-consolidated, with few prominent players operating with a wide product portfolio.

Johnson & Johnson Services, Inc., dominated the global market in 2023. The dominance of the company is owing to the increasing focus on receiving approvals for wound closure products such as hemostats, sutures, among others. This, along with a rising focus on the publication of clinical studies for wound closure products, is also likely to contribute to the growing global wound closure market share.

• In November 2023, Johnson & Johnson Services, Inc., announced the approval of ETHIZIA, an adjunctive hemostat solution clinically proven to achieve sustained hemostasis in difficult-to-control bleeding situations for internal organs.

On the other hand, the increasing focus of players such as 3M, Baxter, among others, on the research and development activities to develop and introduce novel wound closure products, coupled with rising focus on conferences, receiving awards, among others, is likely to support their position in the market.

LIST OF TOP WOUND CLOSURE COMPANIES:

• Johnson & Johnson Services, Inc. (U.S.)


• Baxter (U.S.)


• Medtronic (Ireland)


• Stryker (U.S.)


• 3M (U.S.)


• Smith+Nephew (U.K.)


• B. Braun SE (Germany)


• Boston Scientific Corporation (U.S.)


• Frankenman International Ltd. (China)


• CooperSurgical Inc. (U.S.)


• Intuitive Surgical (U.S.)


• MANI,INC. (Japan)


• Artivion, Inc. (U.S.)


• CP Medical (Riverpoint Medical) (U.S.)


• CONMED Corporation (U.S.)


• Genesis Medtech (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• March 2024 - Intuitive Surgical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for da Vinci 5, the next-generation multiport robotic system.


• February 2024 - Boston Scientific Corporation announced the positive results from the National Institute for Health and Clinical Excellence review on the safety and efficacy of endoscopic sleeve gastroplasty (ESG) with the OverStitch Endoscopic Suturing System. The results stated that the minimally invasive weight loss procedure is safe for bariatric surgery.


• May 2023 - Artivion, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted premarket application (PMA) approval of PERCLOT Absorbable Hemostatic System (PerClot) for use to control bleeding in certain open and laparoscopic surgical procedures.


• May 2023 - Baxter announced that the U.S. Food and Drug Administration (FDA) granted premarket application (PMA) approval for PERCLOT Absorbable Hemostatic System.


• June 2022- Johnson & Johnson Services, Inc. launched the ECHELON 3000 Stapler in the U.S. It is a digitally enabled device that provides surgeons with simple, one-handed powered articulation.

REPORT COVERAGE

The global wound closure market report provides a detailed market analysis. It focuses on key aspects, such as market size & market forecast, market segmentation based on product type, application, and end user, and competitive landscape. It also gives an overview of technological developments, number of key surgical procedures, and COVID-impact analysis.

Besides, the report offers insights into the latest market dynamics, market statistics, market share analysis, and key industry developments. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the market's growth in recent years.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 6.1% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Product Type Sutures Absorbable Non-Absorbable Hemostatic Agents Active Hemostats Passive Hemostats Combination Hemostats Others Staplers Powered Manual Others
By Application Orthopedics Gynecology and Obstetrics General Surgery Ophthalmology Cardiology Others
By End-User Hospitals & ASCs Specialty Clinics Others
By Region North America (By Product Type, By Application, By End-User, and By Country) U.S. Canada Europe (By Product Type, By Application, By End-User, and By Country/Sub-region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Product Type, By Application, By End-User, and By Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Product Type, By Application, By End-User, and By Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Product Type, By Application, By End-User, and By Country/Sub-region) GCC South Africa Rest of the Middle East & Africa